EcoDrugPlus

Proteasome 26s Subunit, Non-Atpase 13

Ensembl ID : ENSCHAG00000019165
Gene Symbol: PSMD13
1 Cross references
209 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 13

Ensembl ID : ENSCHAG00000000194
Gene Symbol: PSMD13
3 Cross references
161 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 14

Ensembl ID : ENSCHAG00000008543
Gene Symbol: PSMD14
3 Cross references
215 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 6

Ensembl ID : ENSCHAG00000026389
Gene Symbol: PSMD6
3 Cross references
213 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 7

Ensembl ID : ENSCHAG00000020169
Gene Symbol: PSMD7
3 Cross references
235 Possible Orthologues:

Proteasome 26s Subunit, Non-Atpase 8

Ensembl ID : ENSCHAG00000023393
Gene Symbol: PSMD8
3 Cross references
213 Possible Orthologues:

Proteasome Subunit Beta 11

Ensembl ID : ENSCHAG00000007236
Gene Symbol: PSMB11
1 Cross references
170 Possible Orthologues:

Proteasome Subunit Beta Type-5-Like

Ensembl ID : ENSCHAG00000021946
Gene Symbol: LOC105894259
2 Cross references
213 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSCHAG00000006322
Gene Symbol: PRMT5
3 Cross references
199 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSCHAG00000024129
Gene Symbol: PRKCD
3 Cross references
204 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSCHAG00000023351
Gene Symbol: PRKCE
1 Cross references
251 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSCHAG00000014796
Gene Symbol: PRKCE
3 Cross references
268 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).